Prostate Cancer - Results from #20140

Variation in general practice prostate-specific antigen testing and prostate cancer outcomes: An ecological study - Abstract July 17, 2014

Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer - Abstract July 17, 2014

Metastases in normal-sized pelvic lymph nodes: Detection with diffusion-weighted MR imaging - Abstract July 17, 2014

Low free testosterone levels predict disease reclassification in men with prostate cancer undergoing active surveillance - Abstract July 17, 2014

Are early continence recovery and oncological outcomes influenced by use of different devices in prostatic apex dissection during laparoscopic radical prostatectomy? - Abstract July 16, 2014

Ertapenem prophylaxis reduces sepsis after transrectal biopsy of the prostate - Abstract July 16, 2014

Skin manifestation of unsuspecting prostate cancer detected by 18F-FDG PET/CT performed to assess underlying multiple myeloma - Abstract July 16, 2014

A phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: Background and rationale of the Radiotherapy - Adjuvant Versus Early Salvage (RAVES) trial - Abstract July 16, 2014

Fiducial markers and spacers in prostate radiotherapy: Current applications - Abstract July 16, 2014

Anxiety and health-related quality of life (HRQL) in patients undergoing active surveillance of prostate cancer in an Australian centre - Abstract July 16, 2014

The feature of metabolic syndrome is a risk factor for biochemical recurrence after radical prostatectomy - Abstract July 16, 2014

Comparison of transperineal mapping biopsy results with whole-mount radical prostatectomy pathology in patients with localized prostate cancer - Abstract July 16, 2014

Quality of life and satisfaction with information after radical prostatectomy, radical external beam radiotherapy and postoperative radiotherapy: A long-term follow-up study - Abstract July 16, 2014

Lycopene can reduce prostate-specific antigen velocity in a phase II clinical study in Chinese population - Abstract July 16, 2014

Combining prostate-specific antigen nadir and time to nadir allows for early identification of patients at highest risk for development of metastasis and death following salvage radiation therapy - Abstract July 16, 2014

Low grade prostate cancer diverges early from high grade and metastatic disease - Abstract July 16, 2014

Intolerance of uncertainty, cognitive complaints, and cancer-related distress in prostate cancer survivors - Abstract July 16, 2014

Abiraterone acetate and castration resistant ductal adenocarcinoma of the prostate - Abstract July 16, 2014

Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases - Abstract July 16, 2014

Performance of the genomic evaluators of metastatic prostate cancer (GEMCaP) tumor biomarker for identifying recurrent disease in African American patients - Abstract July 16, 2014

Page 1008 of 1435